Last update 20 Mar 2025

Pertussis acellular vaccine low-dose(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
Pertussis acellular vaccine low-dose, Reduced antigen content tri-component acellular pertussis vaccine
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesOther Diseases
Active Indication-
Inactive Indication
DiphtheriaRotavirus InfectionsTetanus+ [1]
Originator Organization
GSK PlcGSK Plc
Active Organization-
Inactive Organization
GSK PlcGSK Plc
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Pertussis acellular vaccine low-dose(GlaxoSmithKline Plc)
NCT01110044
/ WithdrawnPhase 2
Immunogenicity and Safety of a Birth Dose of GlaxoSmithKline Biologicals' Reduced-antigen-content Tri-component Pertussis (251154) Vaccine
NCT01262924
/ CompletedPhase 3
A Phase III, Blinded, Randomised, Monocentre, Comparative Clinical Study of the Immunogenicity, Reactogenicity and Safety of a Single Booster Dose of SB Biologicals' Candidate dTpa and pa Vaccines and SB Biologicals' Licensed Td Vaccine in Healthy Adults Aged ≥18 Years
100 Clinical Results associated with Pertussis acellular vaccine low-dose(GlaxoSmithKline Plc)
Login to view more data
100 Translational Medicine associated with Pertussis acellular vaccine low-dose(GlaxoSmithKline Plc)
Login to view more data
100 Patents (Medical) associated with Pertussis acellular vaccine low-dose(GlaxoSmithKline Plc)
Login to view more data
100 Deals associated with Pertussis acellular vaccine low-dose(GlaxoSmithKline Plc)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rotavirus InfectionsPhase 3-
GSK PlcGSK Plc
01 Apr 2010
DiphtheriaPhase 3-
GSK PlcGSK Plc
01 Oct 1997
TetanusPhase 3-
GSK PlcGSK Plc
01 Oct 1997
Whooping CoughPhase 3-
GSK PlcGSK Plc
01 Oct 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free